Intranasal exosomes for treatment of neuroinflammation? Prospects and limitations
Mol Ther
.
2011 Oct;19(10):1754-6.
doi: 10.1038/mt.2011.198.
Authors
Samira Lakhal
1
,
Matthew Ja Wood
Affiliation
1
Department of Physiology, Anatomy, and Genetics, University of Oxford, Oxford, UK. samira.lakhal-littleton@dpag.ox.ac.uk
PMID:
21964306
PMCID:
PMC3188751
DOI:
10.1038/mt.2011.198
No abstract available
Publication types
Comment
MeSH terms
Animals
Anti-Inflammatory Agents / therapeutic use*
Drug Carriers*
Encephalomyelitis, Autoimmune, Experimental / drug therapy*
Exosomes*
Humans
Substances
Anti-Inflammatory Agents
Drug Carriers
Grants and funding
G-0904/PUK_/Parkinson's UK/United Kingdom
G-1109/PUK_/Parkinson's UK/United Kingdom
G0900887/MRC_/Medical Research Council/United Kingdom